212 related articles for article (PubMed ID: 11872234)
21. Early pregnancy decidual lymphocytes beside perforin use Fas ligand (FasL) mediated cytotoxicity.
Crncic TB; Laskarin G; Frankovic KJ; Tokmadzic VS; Strbo N; Bedenicki I; Le Bouteiller P; Tabiasco J; Rukavina D
J Reprod Immunol; 2007 Apr; 73(2):108-117. PubMed ID: 16950518
[TBL] [Abstract][Full Text] [Related]
22. Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand.
Miura Y; Thoburn CJ; Bright EC; Hess AD
Biol Blood Marrow Transplant; 2004 Mar; 10(3):156-70. PubMed ID: 14993881
[TBL] [Abstract][Full Text] [Related]
23. Perforin and Fas induced by IFNgamma and TNFalpha mediate beta cell death by OT-I CTL.
McKenzie MD; Dudek NL; Mariana L; Chong MM; Trapani JA; Kay TW; Thomas HE
Int Immunol; 2006 Jun; 18(6):837-46. PubMed ID: 16574667
[TBL] [Abstract][Full Text] [Related]
24. NK cells recover early and mediate cytotoxicity via perforin/granzyme and Fas/FasL pathways in umbilical cord blood recipients.
Brahmi Z; Hommel-Berrey G; Smith F; Thomson B
Hum Immunol; 2001 Aug; 62(8):782-90. PubMed ID: 11476901
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-12 up-regulates perforin- and Fas-mediated lymphokine-activated killer activity by intestinal intraepithelial lymphocytes.
Ebert EC
Clin Exp Immunol; 2004 Nov; 138(2):259-65. PubMed ID: 15498035
[TBL] [Abstract][Full Text] [Related]
26. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells.
Gaddy J; Broxmeyer HE
Cell Immunol; 1997 Sep; 180(2):132-42. PubMed ID: 9341743
[TBL] [Abstract][Full Text] [Related]
27. Dissociation of NKT stimulation, cytokine induction, and NK activation in vivo by the use of distinct TCR-binding ceramides.
Ortaldo JR; Young HA; Winkler-Pickett RT; Bere EW; Murphy WJ; Wiltrout RH
J Immunol; 2004 Jan; 172(2):943-53. PubMed ID: 14707067
[TBL] [Abstract][Full Text] [Related]
28. Perforin, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells.
Lee RK; Spielman J; Zhao DY; Olsen KJ; Podack ER
J Immunol; 1996 Sep; 157(5):1919-25. PubMed ID: 8757310
[TBL] [Abstract][Full Text] [Related]
29. Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells.
Oshimi Y; Oda S; Honda Y; Nagata S; Miyazaki S
J Immunol; 1996 Oct; 157(7):2909-15. PubMed ID: 8816396
[TBL] [Abstract][Full Text] [Related]
30. Perforin- and Fas-dependent mechanisms of natural killer cell-mediated rejection of incompatible bone marrow cell grafts.
Taylor MA; Ward B; Schatzle JD; Bennett M
Eur J Immunol; 2002 Mar; 32(3):793-9. PubMed ID: 11870623
[TBL] [Abstract][Full Text] [Related]
31. IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells.
Dao T; Mehal WZ; Crispe IN
J Immunol; 1998 Sep; 161(5):2217-22. PubMed ID: 9725214
[TBL] [Abstract][Full Text] [Related]
32. Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.
Homma S; Komita H; Sagawa Y; Ohno T; Toda G
Immunology; 2005 Aug; 115(4):451-61. PubMed ID: 16011514
[TBL] [Abstract][Full Text] [Related]
33. Preferential utilization of the perforin/granzyme pathway for lysis of Epstein-Barr virus-transformed lymphoblastoid cells by virus-specific CD4+ T cells.
Khanolkar A; Yagita H; Cannon MJ
Virology; 2001 Aug; 287(1):79-88. PubMed ID: 11504544
[TBL] [Abstract][Full Text] [Related]
34. MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways.
Benihoud K; Bonardelle D; Bobé P; Kiger N
Eur J Immunol; 1997 Feb; 27(2):415-20. PubMed ID: 9045912
[TBL] [Abstract][Full Text] [Related]
35. Cytotoxic mechanisms in different forms of T-cell-mediated drug allergies.
Kuechler PC; Britschgi M; Schmid S; Hari Y; Grabscheid B; Pichler WJ
Allergy; 2004 Jun; 59(6):613-22. PubMed ID: 15147446
[TBL] [Abstract][Full Text] [Related]
36. Identification of effector cells for TNFalpha-mediated cytotoxicity against WEHI164S cells.
Miyaji C; Watanabe H; Miyakawa R; Yokoyama H; Tsukada C; Ishimoto Y; Miyazawa S; Abo T
Cell Immunol; 2002; 216(1-2):43-9. PubMed ID: 12381349
[TBL] [Abstract][Full Text] [Related]
37. Anti-idiotype antibody induced cellular immunity in mice transgenic for human carcinoembryonic antigen.
Saha A; Chatterjee SK; Foon KA; Bhattacharya-Chatterjee M
Immunology; 2006 Aug; 118(4):483-96. PubMed ID: 16895556
[TBL] [Abstract][Full Text] [Related]
38. Disparate cytotoxic activity of nickel-specific CD8+ and CD4+ T cell subsets against keratinocytes.
Traidl C; Sebastiani S; Albanesi C; Merk HF; Puddu P; Girolomoni G; Cavani A
J Immunol; 2000 Sep; 165(6):3058-64. PubMed ID: 10975816
[TBL] [Abstract][Full Text] [Related]
39. Studies of the mechanism of cytolysis by tumour-infiltrating lymphocytes.
Hishii M; Kurnick JT; Ramirez-Montagut T; Pandolfi F
Clin Exp Immunol; 1999 Jun; 116(3):388-94. PubMed ID: 10361224
[TBL] [Abstract][Full Text] [Related]
40. Acidic pH inhibits non-MHC-restricted killer cell functions.
Fischer B; Müller B; Fischer KG; Baur N; Kreutz W
Clin Immunol; 2000 Sep; 96(3):252-63. PubMed ID: 10964544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]